NCT01915849View on ClinicalTrials.gov

Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

LIK066

LIK066 15 mg, 50 mg and 150 mg

DRUG

Placebo

Trial Locations (1)

91910

Novartis Investigative Site, Chula Vista

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY